Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis – new data bring new questions. Authors' reply

Ikuo Hirano*, Evan S. Dellon, Sandeep K. Gupta, David A. Katzka, Margaret H. Collins, Abigail M. Wojtowicz, Brian Terreri, Wenwen Zhang, Mena Boules, Siddharth Bhatia, Nirav K. Desai

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)1163-1165
Number of pages3
JournalAlimentary Pharmacology and Therapeutics
Volume57
Issue number10
DOIs
StatePublished - May 2023

Funding

: Medical writing support was provided by Joanna L Donnelly, PhD, of PharmaGenesis London, London, UK, and funded by Takeda Pharmaceuticals USA, Inc. The authors' declarations of personal and financial interests are unchanged from those in the original article. Declaration of personal interests 2

ASJC Scopus subject areas

  • Gastroenterology
  • Pharmacology (medical)
  • Hepatology

Cite this